Coya Therapeutics, Inc. Common Stock

COYANASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
4.65 USD
↗ 0.26 (5.94%)🔴AT CLOSE (AS OF 07:31 PM EDT)
🔴Market: CLOSED

Coya Therapeutics, Inc. Common Stock (COYA) is currently trading at $4.65. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. COYA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Sep 14, 2026.

Open?$4.39
High?$4.78
Low?$4.33
Prev. Close?$4.38
Volume?201.5K
Avg. Volume?111.3K
VWAP?$4.63
Rel. Volume?1.81x
Bid / Ask
Bid?$3.84 × 100
Ask?$5.55 × 100
Spread?$1.71
Midpoint?$4.70
Valuation & Ratios
Market Cap?102.7M
Shares Out?23.5M
Float?18.3M
Float %?77.8%
P/E Ratio?N/A
P/B Ratio?2.37
EPS?-$0.92
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
Themes
Biotech - Drug Development›Neuroscience & CNSBiotech - Drug Development›Immunology & Autoimmune
Employees
8
Market Cap
102.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.coyatherapeutics.com
Listed
2022-12-29
Address
12645 MEMORIAL DR., SUITE F1 #305
HOUSTON, TX 77024
Phone: 650.739.3939
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
100
Momentum?
65
Short Sent.?
36
Piotroski F-Score?2/9Weak
Altman Z-Score?12.70Safe
Confidence?46%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?5.95%Elevated
Short Interest?1.1M
Days to Cover?11.5
Free Float18.3M
Avg Daily Volume94.3K
Settlement Date2026-08-31
Financial Health
Current Ratio?13.40Strong
Quick Ratio?13.40Strong
Cash Ratio?12.29Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
67
2.37CHEAP▾
P/S?
Peers
100
S&P
3
12.81HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.6CHEAP▾
EV/Sales?
Peers
100
S&P
19
7.43HIGH▾
Returns & Efficiency
ROE?
S&P
3
-50.1%WEAK▾
ROA?
S&P
3
-45.8%WEAK▾
Cash Flow & Enterprise
FCF?$-15722176
Enterprise Value?$59.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist